Name: 글로벌 시장 동향
SKU: MD1889
Availability: InStock

보고서 요약(국문)

개요
전 세계 심실 보조 장치(VAD) 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
심실 보조 장치(VAD)는 심장 기능이 약하거나 심부전이 있는 사람들의 심장 기능과 혈류를 보조하는 데 사용되는 기계식 펌프입니다. 이는 기능 부전 심장의 기능을 부분적으로 또는 완전히 대체하는 데 사용됩니다.
VAD는 우심실(RVAD), 좌심실(LVAD) 또는 양쪽 심실(BiVAD)을 보조하도록 설계되었습니다. 심장의 부담을 덜어줌으로써 VAD는 수명을 연장하고 피로 및 호흡 곤란과 같은 증상을 개선할 수 있습니다.
시장 동향: 성장 동인 및 제약 요인
심장 질환 및 심부전 부담 증가
심장 질환 발생 건수 증가와 심부전 부담 증가는 시장 성장을 견인할 것으로 예상됩니다. 이러한 요인들은 심실 보조 장치에 대한 수요를 증가시킵니다. 또한, 기술 발전과 장치 승인 증가는 시장 성장을 견인할 것으로 예상됩니다.
예를 들어, 2022년에 발표된 보고서에 따르면 전 세계적으로 심부전 유병률은 약 2,600만 명에 달하며, 이는 전 세계 의료비 증가의 주요 원인입니다. 심부전은 높은 이환율과 사망률을 보이는 세계적인 질환입니다.
또한, 미국 심장학회지(Journal of the American College of Cardiology)에 발표된 보고서에 따르면, 높은 수축기 혈압은 전 세계적으로 심혈관 질환으로 인한 조기 사망의 주요 위험 요인으로, 2021년에는 약 1,080만 명이 심혈관 질환으로 사망했고 전체 사망자는 1,130만 명에 달했습니다. 특히 높은 수축기 혈압은 허혈성 심장 질환 및 뇌졸중 관련 사망과 밀접한 관련이 있습니다. 따라서 위의 요인들이 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

제약 요인
기기 및 시술 비용의 높은 부담
심실 보조 장치 사용과 관련된 높은 비용과 혈전 및 출혈과 같은 심각한 합병증은 전 세계 심실 보조 장치 시장 성장을 저해하는 요인입니다.
세분화 분석
전 세계 심실 보조 장치 시장은 제품 유형, 설계 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.

좌심실 보조 장치(LVAD) 부문은 시장 점유율의 48.3%를 차지했습니다.
좌심실 보조 장치(LVAD)는 다른 유형의 심실 보조 장치에 비해 여러 장점이 있어 전 세계 심실 보조 장치 시장에서 지배적인 점유율을 차지할 것으로 예상됩니다. 좌심실 보조 장치(LVAD)는 심장 기능 장애 환자에게 가장 흔하게 사용되는 장치이며, 대부분의 경우 충분한 효과를 나타냅니다.
좌심실 보조 장치(LVAD)는 진행성 심부전 환자에게 이식되는 기계 장치로, 심장이 혈액을 더 효율적으로 펌프질하도록 돕고, 장기 기증을 기다리는 진행성 심부전 환자에게 도움이 될 수 있습니다. 또한, 혈류량을 증가시켜 신장, 간, 뇌 및 기타 장기의 기능을 개선합니다.
좌심실 보조 장치(LVAD)는 심장의 좌심실이 대동맥이라는 큰 혈관을 통해 신체의 나머지 부분으로 혈액을 펌프질하도록 돕습니다.
또한, 심장 질환 환자 수 증가, 고령 인구 증가, 그리고 새로운 제품 출시 증가 등이 LVAD 시장 성장을 견인하고 있습니다. 이러한 기기들은 해당 부문의 성장을 견인할 것으로 예상됩니다. 따라서 위의 요인들은 시장 점유율에서 중요한 위치를 차지할 것으로 예상됩니다.
지리적 분석
북미는 전 세계 심실 보조 장치 시장에서 중요한 위치를 차지할 것으로 예상됩니다.
북미는 기술 발전과 심장 질환 부담 증가로 인해 심실 보조 장치 시장에서 지배적인 점유율을 차지하고 있으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.
예를 들어, 2021년 미국 질병통제예방센터(CDC) 보고서에 따르면 심장 질환은 미국에서 남성, 여성, 그리고 대부분의 인종 및 민족 집단에서 주요 사망 원인입니다. 미국에서는 33초마다 한 명씩 심혈관 질환으로 사망하며, 2021년에는 약 69만 5천 명이 심장 질환으로 사망했습니다.
2023년 CDC 보고서에 따르면 미국에서는 매년 약 80만 5천 명이 심장마비를 겪는 것으로 추정됩니다. 이 중, 60만 5천 건은 첫 심근경색이며, 20만 건은 이미 심근경색을 경험한 사람들에게 발생합니다.
따라서 심장 질환 부담의 증가와 해당 지역의 의료 기술 발전, 그리고 주요 기업들의 존재는 이 지역 시장 성장을 견인할 것으로 예상됩니다.
COVID-19 영향 분석
COVID-19는 심실 보조 장치 시장에 부정적인 영향을 미쳤습니다. 심혈관 수술 건수 감소와 봉쇄 기간 동안 병원 폐쇄는 시장 성장에 악영향을 미쳤습니다. 바이러스 확산으로 인해 사람들이 치료를 위해 병원을 방문하는 것을 꺼렸기 때문입니다. 따라서 COVID-19는 시장 성장을 저해했습니다.
경쟁 환경
상당한 시장 점유율을 차지하는 주요 기업으로는 Abbott Laboratories, Abiomed Inc, Berlin Heart GmbH, Medtronic Plc, Jarvik Heart, Inc., EVAHEART, INC., Cirtec, CorWave SA, Calon Cardio-Technology Ltd 및 Teleflex가 있습니다. CorWave는 시리즈 C 투자 유치를 통해 총 6,400만 달러를 확보하여 웨이브 멤브레인 LVAD의 임상 시험 및 초기 생산에 투자할 계획이라고 발표했습니다.

• 2023년 6월 20일, IIT 칸푸르는 세계에서 가장 진보된 좌심실 보조 장치(LVAD) 개발을 목표로 의료 기술 분야에 진출했습니다.

보고서 구매 이유

• 제품 유형, 설계, 적용 분야, 최종 사용자 및 지역별 글로벌 심실 보조 장치 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악하기 위해

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴하기 위해

• 모든 세그먼트를 포함한 심실 보조 장치 시장 수준의 다양한 데이터가 담긴 엑셀 시트

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 엑셀 파일 제공

글로벌 심실 보조 장치 시장 보고서는 약 69개의 표, 68개의 그림, 그리고 185페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Ventricular Assist Devices Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
A ventricular assist device (VAD) is a mechanical pump that is used to support heart function and blood flow in people with weak or failing hearts. It is used either to partially or to completely replace the function of a failing heart.
VADs are designed to assist either the right ventricle (RVAD) or the left ventricle (LVAD) or to assist both ventricles (BiVAD). By relieving the heart's workload, a VAD can prolong life and improve symptoms such as fatigue and breathlessness.
Market Dynamics: Drivers & Restraints
Increasing cardiac disease and heart failure burden
The increase in the number of cardiac diseases and the increase in the heart failure burden is expected to drive the market growth. These factors increase the demand for ventricular assist devices. Additionally, the increase in technological advancements and the increase in the approvals of the devices are also expected to drive the market.
For instance, according to the report published in 2022, it is estimated that heart failure has an estimated prevalence of 26 million people worldwide and contributes to increased healthcare costs worldwide. Heart failure remains a highly prevalent disorder worldwide with a high morbidity and mortality rate.
Additionally, according to the report published in the Journal of the American College of Cardiology, high systolic blood pressure remains the leading modifiable risk factor globally for attributable premature cardiovascular deaths, which was about 10.8 million cardiovascular deaths and 11.3 million deaths overall in 2021, and has been particularly linked to ischemic heart disease and stroke-related deaths. Thus, the above factors are expected to drive the market growth in the forecast period.
Restraint
High costs of devices and the procedures
Factors such as high cost and serious complications involved with the usage of ventricular assist devices such as blood clots and bleeding, are restricting the global ventricular assist devices market growth.
Segment Analysis
The global ventricular assist devices market is segmented based on product type, design application, end-user and region.
Left ventricular assist device segment accounted for 48.3% of the market share
The left ventricular assist devices segment is expected to hold a dominant share in the global ventricular assist devices market because of the advantages of the LAVD over other types.. The left ventricular assist device (LVAD) is the most common device applied to a defective heart (it is sufficient in most cases.
Left Ventricular Assist Devices (LVADs) are mechanical devices that are implanted in patients with advanced heart failure, help the heart pump blood more effectively, and could benefit patients with advanced heart failure as they await donors. They improve the function of the kidneys, liver, brain, and other organs by increasing blood flow to the body.
Left Ventricular Assist Device (LVAD) helps the left side of the heart pump blood to a large blood vessel called the aorta and to the rest of the body.
Additionally, the increase in the number of heart diseases, an increase in the geriatric population, and the increase in the number of launches of the devices are expected to drive the segment’s growth. Thus, the above factors are expected to hold a significant position in the market share.
Geographical Analysis
North America is expected to hold a significant position in the global ventricular assist devices market share
North America holds a dominant share in the ventricular assist devices market share owing to technological advancements and, an increase in the burden of heart diseases and is expected to continue throughout the forecast period.
For instance, according to the report by CDC in 2021, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds in the United States from cardiovascular disease and about 695,000 people in the United States died from heart disease in 2021.
According to the report by the Centers for Disease Control & Prevention (CDC) in 2023, it is estimated that about 805,000 people in the United States have a heart attack every year. Among these, 605,000 are a first heart attack and 200,000 happen to people who have already had a heart attack.
Thus, an increase in the burden of heart diseases, and also increase in the advancements in the region, and the presence of major companies in the region are expected to drive market growth in the region.
COVID-19 Impact Analysis
The COVID-19 has impacted the ventricular assist devices market negatively. The reduction in the number of cardiovascular surgeries and the closure of hospitals during the period of lockdown has impacted the market growth. People refused to visit hospitals for treatment procedures because of the spread of the virus. Thus, COVID-19 has reduced the growth of the market.
Competitive Landscape
The leading companies with a significant market share include Abbott Laboratories, Abiomed Inc, Berlin Heart GmbH, Medtronic Plc, Jarvik Heart, Inc., EVAHEART, INC., Cirtec, CorWave SA, Calon Cardio-Technology Ltd, and Teleflex Incorporated.
Key Developments
• On June 20, 2023, CorWave declared that its Series C round has brought in a total of $64 million to fund entry into clinical trials and initial manufacturing of its wave membrane LVAD.
• On January 6, 2022, the IIT Kanpur has forayed into the field of medical technology with its ambition of creating the world's most advanced Left Ventricular Assist Device (LVAD).
Why Purchase the Report?
• To visualize the global ventricular assist devices market segmentation based on product type, design, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of ventricular assist devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global ventricular assist devices market report would provide approximately 69 tables, 68 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Design
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing cardiac disease and heart failure burden
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. High costs of devices and the procedures
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Left Ventricular Assist Device *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Right Ventricular Assist Device
7.4. Biventricular Assist Device
8. By Design
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
8.1.2. Market Attractiveness Index, By Design
8.2. Implantable Ventricular Assist Devices *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Transcutaneous Ventricular Assist Devices
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Bridge to Candidacy Therapy *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Bridge to Transplant Therapy
9.4. Bridge to Recovery Therapy
9.5. Destination Therapy
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers
10.4. Specialty Clinics
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Abbott Laboratories *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Abiomed Inc
13.3. Berlin Heart GmbH
13.4. Medtronic Plc
13.5. Jarvik Heart, Inc
13.6. EVAHEART, INC.
13.7. Cirtec
13.8. CorWave SA
13.9. Calon Cardio-Technology Ltd
13.10. Teleflex Incorporated.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Abbott Laboratories, 4. Key Developments, Abiomed Inc, Berlin Heart GmbH, Medtronic Plc, Jarvik Heart, Inc, EVAHEART, INC., Cirtec, CorWave SA, Calon Cardio-Technology Ltd, Teleflex Incorporated.

표 목록 (Tables)

List of Tables

Table 1 Global Ventricular Assist Devices Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Ventricular Assist Devices Market Value, By Design, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Ventricular Assist Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Ventricular Assist Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Ventricular Assist Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Ventricular Assist Devices Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Ventricular Assist Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Ventricular Assist Devices Market Value, By Design, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Ventricular Assist Devices Market Value, By Design, 2021-2030 (US$ Million)

Table 10 Global Ventricular Assist Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Ventricular Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 12 Global Ventricular Assist Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Ventricular Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Ventricular Assist Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Ventricular Assist Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Ventricular Assist Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Ventricular Assist Devices Market Value, By Design, 2021-2030 (US$ Million)

Table 18 North America Ventricular Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 19 North America Ventricular Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Ventricular Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Ventricular Assist Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Ventricular Assist Devices Market Value, By Design, 2021-2030 (US$ Million)

Table 23 South America Ventricular Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 24 South America Ventricular Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Ventricular Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Ventricular Assist Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Ventricular Assist Devices Market Value, By Design, 2021-2030 (US$ Million)

Table 28 Europe Ventricular Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 29 Europe Ventricular Assist Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Ventricular Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Ventricular Assist Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Ventricular Assist Devices Market Value, By Design, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Ventricular Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Ventricular Assist Devices Market Value, By End-User , 2021-2030 (US$ Million)

Table 35 Asia-Pacific Ventricular Assist Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Ventricular Assist Devices Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Ventricular Assist Devices Market Value, By Design, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Ventricular Assist Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Ventricular Assist Devices Market Value, By End-User , 2021-2030 (US$ Million)

Table 40 Abbott Laboratories: Overview

Table 41 Abbott Laboratories: Product Portfolio

Table 42 Abbott Laboratories: Key Developments

Table 43 Abiomed Inc: Overview

Table 44 Abiomed Inc: Product Portfolio

Table 45 Abiomed Inc: Key Developments

Table 46 Berlin Heart GmbH: Overview

Table 47 Berlin Heart GmbH: Product Portfolio

Table 48 Berlin Heart GmbH: Key Developments

Table 49 Medtronic Plc: Overview

Table 50 Medtronic Plc: Product Portfolio

Table 51 Medtronic Plc: Key Developments

Table 52 Jarvik Heart, Inc: Overview

Table 53 Jarvik Heart, Inc: Product Portfolio

Table 54 Jarvik Heart, Inc: Key Developments

Table 55 EVAHEART, INC.: Overview

Table 56 EVAHEART, INC.: Product Portfolio

Table 57 EVAHEART, INC.: Key Developments

Table 58 Cirtec: Overview

Table 59 Cirtec: Product Portfolio

Table 60 Cirtec: Key Developments

Table 61 CorWave SA: Overview

Table 62 CorWave SA: Product Portfolio

Table 63 CorWave SA: Key Developments

Table 64 Calon Cardio-Technology Ltd: Overview

Table 65 Calon Cardio-Technology Ltd: Product Portfolio

Table 66 Calon Cardio-Technology Ltd: Key Developments

Table 67 Teleflex Incorporated.: Overview

Table 68 Teleflex Incorporated.: Product Portfolio

Table 69 Teleflex Incorporated.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Ventricular Assist Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Ventricular Assist Devices Market Share, By Design, 2022 & 2030 (%)

Figure 4 Global Ventricular Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Ventricular Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Ventricular Assist Devices Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Ventricular Assist Devices Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Left Ventricular Assist Device Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Right Ventricular Assist Device Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Biventricular Assist Device Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 11 Global Ventricular Assist Devices Market Y-o-Y Growth, By Design, 2022-2030 (%)

Figure 12 Implantable Ventricular Assist Devices Design in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 13 Transcutaneous Ventricular Assist Devices Design in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Global Ventricular Assist Devices Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 15 Bridge to Candidacy Therapy Application in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Bridge to Transplant Therapy Application in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 17 Bridge to Recovery Therapy Application in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Destination Therapy Application in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 19 Global Ventricular Assist Devices Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 20 Hospitals End-User in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Ambulatory Surgical Centers End-User in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 22 Specialty Clinics End-User in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 23 Others End-User in Global Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 24 Global Ventricular Assist Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 25 North America Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 26 Asia-Pacific Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 27 Europe Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 28 South America Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 29 Middle East and Africa Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 30 North America Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 31 North America Ventricular Assist Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 32 North America Ventricular Assist Devices Market Share, By Design, 2022 & 2030 (%)

Figure 33 North America Ventricular Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 34 North America Ventricular Assist Devices Market Share, By End-User , 2022 & 2030 (%)

Figure 35 North America Ventricular Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 36 South America Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 37 South America Ventricular Assist Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 38 South America Ventricular Assist Devices Market Share, By Design, 2022 & 2030 (%)

Figure 39 South America Ventricular Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 40 South America Ventricular Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 41 South America Ventricular Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 42 Europe Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 43 Europe Ventricular Assist Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 44 Europe Ventricular Assist Devices Market Share, By Design, 2022 & 2030 (%)

Figure 45 Europe Ventricular Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 46 Europe Ventricular Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 47 Europe Ventricular Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 48 Asia-Pacific Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 49 Asia-Pacific Ventricular Assist Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 50 Asia-Pacific Ventricular Assist Devices Market Share, By Design, 2022 & 2030 (%)

Figure 51 Asia-Pacific Ventricular Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 52 Asia-Pacific Ventricular Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 53 Asia-Pacific Ventricular Assist Devices Market Share, By Country, 2022 & 2030 (%)

Figure 54 Middle East & Africa Ventricular Assist Devices Market Value, 2021-2030 (US$ Million)

Figure 55 Middle East & Africa Ventricular Assist Devices Market Share, By Product Type, 2022 & 2030 (%)

Figure 56 Middle East & Africa Ventricular Assist Devices Market Share, By Design, 2022 & 2030 (%)

Figure 57 Middle East & Africa Ventricular Assist Devices Market Share, By Application, 2022 & 2030 (%)

Figure 58 Middle East & Africa Ventricular Assist Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 59 Abbott Laboratories: Financials

Figure 60 Abiomed Inc: Financials

Figure 61 Berlin Heart GmbH: Financials

Figure 62 Medtronic Plc: Financials

Figure 63 Jarvik Heart, Inc: Financials

Figure 64 EVAHEART, INC.: Financials

Figure 65 Cirtec: Financials

Figure 66 CorWave SA: Financials

Figure 67 Calon Cardio-Technology Ltd: Financials

Figure 68 Teleflex Incorporated.: Financials

글로벌 심실 보조 장치 시장 – 2023-2030

Global Ventricular Assist Devices Market - 2023-2030